Accessibility Menu
 
BioVie logo

BioVie

(NASDAQ) BIVI

Current Price$1.30
Market Cap$10.03M
Since IPO (2014)-100%
5 Year-100%
1 Year-88%
1 Month+6%

BioVie Financials at a Glance

Market Cap

$10.03M

Revenue (TTM)

$0.00

Net Income (TTM)

$17.43M

EPS (TTM)

$-5.08

P/E Ratio

-0.26

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$1.30

Volume

14,167

Open

$1.35

Previous Close

$1.33

Daily Range

$1.28 - $1.35

52-Week Range

$1.06 - $13.20

BIVI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioVie

Industry

Biotechnology

Employees

13

CEO

Cuong Viet Do, MBA

Headquarters

Carson City, NV 89703, US

BIVI Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-81%

Return on Capital

-93%

Return on Assets

-77%

Earnings Yield

-3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.03M

Shares Outstanding

7.54M

Volume

14.17K

Short Interest

0.00%

Avg. Volume

109.21K

Financials (TTM)

Gross Profit

$229.38K

Operating Income

$18.07M

EBITDA

$16.98M

Operating Cash Flow

$19.03M

Capital Expenditure

$0.00

Free Cash Flow

$19.03M

Cash & ST Invst.

$17.54M

Total Debt

$349.89K

BioVie Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$57.34K

N/A

Gross Margin

0.00%

N/A

Market Cap

$10.03M

N/A

Market Cap/Employee

$716.64K

N/A

Employees

14

N/A

Net Income

$6.07M

+14.7%

EBITDA

$6.01M

+17.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$20.23M

-15.8%

Accounts Receivable

$195.48K

N/A

Inventory

$0.00

N/A

Long Term Debt

$232.52K

-26.2%

Short Term Debt

$82.40K

+22.8%

Return on Assets

-77.48%

N/A

Return on Invested Capital

-93.34%

N/A

Free Cash Flow

$4.44M

+48.3%

Operating Cash Flow

$4.44M

+48.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KZIAKazia Therapeutics Limited
$7.17+0.70%
ARTLArtelo Biosciences, Inc.
$5.87-23.43%
TOVXTheriva Biologics, Inc.
$0.21+0.71%
GLMDGalmed Pharmaceuticals Ltd.
$0.57-3.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.80-0.02%
IBRXImmunityBio
$7.41-0.21%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.02%

Questions About BIVI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.